Related Experiment Video

Updated: Aug 14, 2026

Ex Vivo Culture of Primary Human Fallopian Tube Epithelial Cells
11:46

Ex Vivo Culture of Primary Human Fallopian Tube Epithelial Cells

Published on: May 9, 2011

[Biologic therapy and epithelial ovarian cancer]

M Porpiglia1, R Vicelli, A Durando

  • 1Cattedra C, Dipartimento di Discipline, Ginecologiche e Ostetriche, Day Hospital Oncologico Universitario, Azienda Ospedaliera OIRM-S. Anna, Torino, Italy.

Minerva Ginecologica
|February 20, 2004
PubMed

Insights

New biologic therapies offer targeted ovarian cancer treatment with fewer side effects. Gene and immunological therapies show promise for correcting cancer cell defects and boosting immune response, reducing chemotherapy toxicity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunotherapy

Background:

  • Ovarian cancer treatment relies on identifying prognostic and predictive factors for personalized strategies.
  • Growing interest exists in biologic therapies targeting neoplastic cells and immune responses.
  • Chemotherapy side effects like myelotoxicity necessitate strategies to reduce toxicity.

Purpose of the Study:

  • To review current data on biologic therapies for ovarian cancer.
  • To highlight novel approaches like gene and immunological therapies.
  • To discuss the potential of these therapies in improving treatment specificity and reducing toxicity.

Main Methods:

  • Literature review of recent studies on ovarian cancer biologic therapy.
  • Analysis of data on gene therapy for correcting genetic lesions.
  • Evaluation of immunological therapy for activating specific immune responses.

Main Results:

  • Biologic therapies demonstrate potential for greater specificity and reduced toxicity compared to conventional treatments.
  • Gene therapy offers a route to modulate drug resistance in stem cells, mitigating chemotherapy side effects.
  • Immunological approaches aim to enhance the body's own anti-cancer immune response.

Conclusions:

  • Biologic therapies represent a promising frontier in ovarian cancer treatment.
  • Further biological and molecular studies are essential for clinical translation.
  • Personalized therapeutic strategies incorporating these novel treatments may improve patient outcomes.

More Related Videos

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages08:26

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Published on: February 23, 2024

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.